TrialEuropean journal of haematology2022

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.

Henrik Gregersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.